Abstract | BACKGROUND: MATERIALS AND METHODS: Hepa 1c1c7 hepatoma cells were implanted under the dorsal skin of female CD-1-nu/nu immunodeficient mice. One group of animals was given 100 mg/kg body weight/day BGP-15 intraperitoneally during tumor development. Vascularization, apoptotic and mitotic indices were determined by the histological and immunohistochemical analysis of the tumors. VEGF and GLUT-1 expressions were measured by Northern blot. RESULTS: The in vivo administration of BGP-15 resulted in a decrease in tumor weight and mitotic index, while it did not affect the apoptotic rate in the xenograft. Furthermore, BGP-15 treatment depressed microvascular density and the level of VEGF mRNA by 50%, and similarly decreased GLUT-1 mRNA levels. CONCLUSION: These findings suggest that BGP-15 suppresses hepatoma development by affecting angiogenesis.
|
Authors | Tamás Kardon, Gábor Nagy, Miklós Csala, András Kiss, Zsuzsa Schaff, Péter Literáti Nagy, Livius Wunderlich, Gábor Bánhegyi, József Mandl |
Journal | Anticancer research
(Anticancer Res)
2006 Mar-Apr
Vol. 26
Issue 2A
Pg. 1023-8
ISSN: 0250-7005 [Print] Greece |
PMID | 16619502
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glucose Transporter Type 1
- Oximes
- Piperidines
- RNA, Messenger
- Vascular Endothelial Growth Factor A
- BGP 15
|
Topics |
- Animals
- Apoptosis
(drug effects)
- Cell Growth Processes
(drug effects)
- Female
- Glucose Transporter Type 1
(biosynthesis, genetics)
- Liver Neoplasms, Experimental
(blood supply, drug therapy, metabolism, pathology)
- Mice
- Mice, Nude
- Mitosis
(drug effects)
- Neovascularization, Pathologic
(drug therapy, metabolism, pathology)
- Oximes
(pharmacology)
- Piperidines
(pharmacology)
- RNA, Messenger
(biosynthesis, genetics)
- Vascular Endothelial Growth Factor A
(biosynthesis, genetics)
- Xenograft Model Antitumor Assays
|